Screening for Hesitancy to Optimize Talk
NCT02708745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 562
Last updated 2019-10-01
Summary
The overall goal of this project is to determine whether integrating a novel parent-report measure of vaccine hesitancy into pediatric primary care is effective in improving acceptance of childhood vaccines among vaccine-hesitant parents.
Conditions
- Preventive Health Services
Interventions
- BEHAVIORAL
-
Intervention Survey
- BEHAVIORAL
-
Placebo Survey
Sponsors & Collaborators
-
Kaiser Permanente
collaborator OTHER - collaborator OTHER
-
Seattle Children's Hospital
lead OTHER
Principal Investigators
-
Douglas J Opel, MD, MPH · Seattle Children's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2018-06-11
- Completion
- 2018-06-11
More Related Trials
-
Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters
NCT06074237 ·Status: COMPLETED ·Phase: NA
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED
-
Educational Videos to Address Vaccine Hesitancy in Childhood Immunization
NCT05390697 ·Status: COMPLETED ·Phase: NA
-
Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children
NCT02556996 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Comparison Study of Menactra® in US Children
NCT00700635 ·Status: COMPLETED ·Phase: PHASE2
-
ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage
NCT06882070 ·Status: COMPLETED
-
A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)
NCT00836498 ·Status: TERMINATED ·Phase: PHASE1
-
NeisVac-C Single Prime Study in Infants
NCT01218451 ·Status: COMPLETED ·Phase: PHASE3
-
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
NCT04658914 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
NCT06350058 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel
NCT00368316 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination
NCT01915888 ·Status: COMPLETED
-
Improving Rotavirus Vaccine Immune Response
NCT01825109 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.
NCT00471081 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine
NCT01939158 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
NCT01575197 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children
NCT00311415 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
NCT06337071 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age
NCT00310674 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)
NCT00310856 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers
NCT00186927 ·Status: SUSPENDED ·Phase: PHASE1
-
Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults
NCT01509846 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
NCT00995813 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Healthy Toddlers
NCT00387569 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Rotavirus Immunization in Nicaragua
NCT01133808 ·Status: COMPLETED